Incidence and clinical outcomes of extended duration support in patients with Impella 5.5 - Analysis from the LOQI Registry

Purpose: Impella 5.5 pumps are increasingly used in cardiogenic shock (CS) for extended hemodynamic support (>14 days). Rates of adverse events have not been well-characterized during longer durations of support. Therefore, we sought to define patient characteristics and adverse event rates in short...

Descrizione completa

Dettagli Bibliografici

Autori principali:	David Kaczorowski, MD, Vidang P. Nguyen, MD, Aasim Afzal, MD, Scott C. Silvestry, MD, Ahmad Zeeshan, MD, Naveena Yanamala, PhD, Ray Matthews, MD, Rothy Chhim, MS, Sanjeev Aggarwal, MD, Sami I. Somo, PhD, Gavin W. Hickey, MD
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2026-08-01
Serie:	JHLT Open
Soggetti:	Cardiogenic Shock Impella 5.5 Mechanical Circulatory Support Extended support Long duration support Axial flow pump
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2950133426001072
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!